Development Progress Meetings. Upon the request of Shionogi or Lilly, but not more than twice per year, Anthera shall meet with Shionogi and Lilly to review the status of the development of Licensed Products by Anthera and its Affiliates and sublicensees. Such meetings may be held telephonically.
Appears in 3 contracts
Sources: License Agreement, License Agreement (Anthera Pharmaceuticals Inc), License Agreement (Anthera Pharmaceuticals Inc)